Poolbeg Pharma PLC
Status: Publicly traded
Direct answer
Poolbeg Pharma PLC is publicly traded on LSE under the ticker POLB.L.
Poolbeg Pharma plc is a clinical-stage biopharmaceutical company based in the United Kingdom, focused on developing treatments for infectious diseases. Its pipeline features several key programs: POLB 001, a p38 MAP Kinase inhibitor intended for severe influenza; POLB 002, a pioneering, in-licensed RNA-based immunotherapy administered intranasally to combat respiratory virus infections; and POLB 003, an...
Can you invest in Poolbeg Pharma PLC?
Yes. Poolbeg Pharma PLC trades publicly on LSE as POLB.L.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Poolbeg Pharma PLC
Detailed equity research is provided by MarketSnap.